Wells Fargo
BFRI icon

Wells Fargo’s Biofrontera BFRI Stock Holding History

Wells Fargo’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-91
Closed -$82 – 6916
2024
Q2 		$82 Buy
91
+84
+1,200% +$116 ﹤0.01% 6269
2024
Q1 		$11 Hold
7
– – ﹤0.01% 7265
2023
Q4 		$19 Buy
7
+1
+17% +$4 ﹤0.01% 7235
2023
Q3 		$53 Hold
6
– – ﹤0.01% 6903
2023
Q2 		$66 Hold
6
– – ﹤0.01% 6978
2023
Q1 		$74 Hold
6
– – ﹤0.01% 7006
2022
Q4 		$110 Buy
6
+1
+20% +$20 ﹤0.01% 6768
2022
Q3 		$0 Buy
5
+2
+67% +$55 ﹤0.01% 6660
2022
Q2 		$0 Hold
3
– – ﹤0.01% 6801
2022
Q1 		$0 Buy
3
+2
+200% +$145 ﹤0.01% 7059
2021
Q4 		$0 Buy
+1
New +$109 ﹤0.01% 7216

Other funds holding BFRI

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo's BFRI Position: Q3 2024 in Review

Wells Fargo sold out of Biofrontera (BFRI) in Q3 2024, closing a stake of 91 shares — an estimated $82 sold.

Wells Fargo first reported a position in BFRI in Q4 2021 and held it in 11 quarters. The position peaked at $110 in Q4 2022. 9 funds tracked by Wall St. Rank hold BFRI as of Q3 2024.

  • Wells Fargo reported no remaining Biofrontera position as of Q3 2024 after selling out during the quarter.
  • Wells Fargo sold 91 Biofrontera shares in Q3 2024, an estimated $82.
  • Wells Fargo first reported a position in Biofrontera in Q4 2021 and held it in 11 quarters.
  • Wells Fargo's Biofrontera position peaked at $110 in Q4 2022.
  • 9 funds tracked by Wall St. Rank held Biofrontera as of Q3 2024.

Based on Wells Fargo's 13F filing for Q3 2024, filed 13 Nov 2024.